Amgen announces $13.4bn acquisition of Celgene psoriasis treatment
27-08-2019
Tero Vesalainen / Shutterstock.com
Pharmaceutical companies Merck & Co, Eli Lilly, and Amgen are suing the US Department of Health and Human Services (HSS) over proposed rules which would force companies to disclose the list prices of drugs in TV advertisements.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Merck, Eli Lilly, Amgen, National Association of Advertisers, Department of Health and Human Services, list price, drug prices, advertising
